Mindi Bee, NURSE | |
201 Highland Ave, Claysville, PA 15323-2391 | |
(304) 551-3840 | |
Not Available |
Full Name | Mindi Bee |
---|---|
Gender | Female |
Speciality | Licensed Practical Nurse |
Location | 201 Highland Ave, Claysville, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1306556774 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
164W00000X | Licensed Practical Nurse | 23177 (West Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mindi Bee, NURSE Po Box 81, Claysville, PA 15323-0081 Ph: () - | Mindi Bee, NURSE 201 Highland Ave, Claysville, PA 15323-2391 Ph: (304) 551-3840 |
News Archive
Much orthopaedic research has been devoted to determining why women are far more susceptible to knee ligament injuries than men. According to a new study, the answer may lie in geometry - the length and shape of a patient's knee bone - more than gender.
Every year, millions of senior citizens fall -; threatening their health, independence and even their lives. Fall injuries also rack up $31 billion annually in medical expenses, which is expected to rise as 10,000 people in the U.S. turn 65 every day.
In a paper published in PLoS Medicine researchers from the German Genome Research Network have analysed the expression of thousands of genes from patients with inflammatory bowel disease (ulcerative colitis and Crohn disease) using a genome wide approach to produce a comprehensive picture of which genes are activated in these conditions.
Strategic partnerships between the pharmaceuticals industry and the biotechnology sector are making breast cancer therapeutics one of the most dynamic segments in the overall oncology market.
Based on the Action Plan 2012, Evotec decided in March 2009 to strengthen its discovery alliances, creating the central vehicle for growth, and to implement strict cost cutting and restructuring measures. The Company reduced headcount in administrative and clinical development functions, reprioritised its R&D activities, concentrated its operations in Europe and closed the former facility of Renovis, Inc. in South San Francisco.
› Verified 8 days ago